| 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0230 | 0.0619 | -62.84 | 0.1120 | | 每股净资产（元） | 1.25 | 1.24 | 0.81 | 1.21 | | 每股公积金(元) | 0 | 0 | 0 | 0 | | 每股未分配利润(元) | 0.33 | 0.30 | 10 | 0.25 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 11.82 | 9.88 | 19.64 | 13.65 | | 净利润(亿元) | 0.19 | 0.51 | -62.75 | 0.93 | | 净资产收益率(%) | 1.84 | 5.05 | -63.56 | 9.29 | 一、主要会计数据和财务指标 三、分红送配方案情况 数据四舍五入，查看更多财务数据>> 不分配不转增 | 名称 | 持有数量(万股) | 占总股本比例 | 增减情况(万 | | --- | --- | --- | ...

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.5341 | -0.2309 | -131.31 | 0.1578 | | 每股净资产（元） | 4.14 | 4.69 | -11.73 | 4.9 | | 每股公积金(元) | 1.96 | 1.96 | 0 | 1.88 | | 每股未分配利润(元) | 0.99 | 1.54 | -35.71 | 1.82 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 12.07 | 12.87 | -6.22 | 10.56 | | 净利润(亿元) | -1.23 | -0.53 | -132.08 | 0.36 | | 净资产收益率(%) | -12.09 | -4.81 | -151.35 | 3.28 | 数据四舍五入，查看更多财务数据>> 前十大流通股东累计持有： 6407.97万股，累计占流通股比： 34.26%，较上期变化： -5 ...

Financial Performance - The company's basic earnings per share decreased to 0.1500 yuan in 2024 from 0.2100 yuan in 2023, representing a decline of 28.57% [1] - The net profit for 2024 was 0.4 billion yuan, down 31.03% from 0.58 billion yuan in 2023 [1] - Operating revenue fell to 2.69 billion yuan in 2024, a decrease of 14.33% compared to 3.14 billion yuan in 2023 [1] - The return on equity (ROE) dropped to 6.08% in 2024 from 8.61% in 2023, marking a decline of 29.38% [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 14.1447 million shares, accounting for 17.6% of the circulating shares, which is a decrease of 1.1042 million shares from the previous period [1] - Guangdong Yongshun Biopharmaceutical Co., Ltd. remains unchanged with 360.00 million shares, representing 4.48% of total share capital [2] - Cai Jianping's holdings decreased by 22.00 million shares, now totaling 319.97 million shares, or 3.98% of total share capital [2] Dividend Distribution - The company announced a dividend distribution plan of 1.3 yuan per share (including tax) [2]

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.2700 | -0.3500 | 22.86 | -0.2600 | | 每股净资产（元） | 2.82 | 2.75 | 2.55 | 2.49 | | 每股公积金(元) | 2.33 | 2.29 | 1.75 | 1.59 | | 每股未分配利润(元) | -1.23 | -1.04 | -18.27 | -0.74 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.79 | 2.1 | -14.76 | 1.56 | | 净利润(亿元) | -1.21 | -1.56 | 22.44 | -1.11 | | 净资产收益率(%) | -9.70 | -12.36 | 21.52 | -10.77 | 数据四舍五入，查看更多财务数据>> 前十大流通股东累计持有： 19956.75万股，累计占流通股比： 44.41%，较上期变化： - ...

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.2905 | -0.1723 | -68.6 | -0.0940 | | 每股净资产（元） | 2.56 | 2.85 | -10.18 | 3.04 | | 每股公积金(元) | 0.85 | 0.85 | 0 | 0.87 | | 每股未分配利润(元) | 0.54 | 0.83 | -34.94 | 1.01 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.77 | 1.82 | -2.75 | 2.14 | | 净利润(亿元) | -0.58 | -0.34 | -70.59 | -0.19 | | 净资产收益率(%) | -10.75 | -5.85 | -83.76 | -3.05 | 数据四舍五入，查看更多财务数据>> | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | -- ...

| 名称 | 持有数量(万股) | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 浙江金鹰集团有限公司 | 18327.35 | 50.25 | 不变 | | 白恒斌 | 409.51 | 1.12 | 22.95 | | 顾兴华 | 358.59 | 0.98 | 不变 | | 吴建新 | 200.00 | 0.55 | -21.01 | | 董淑芬 | 200.00 | 0.55 | 不变 | | 毛爽 | 188.48 | 0.52 | 新进 | | 黄宇 | 170.47 | 0.47 | 35.55 | | 何凤 | 168.39 | 0.46 | 27.36 | | MORGAN STANLEY & CO. INTERNATIONAL PLC. | 134.47 | 0.37 | -36.38 | | 刘洪志 | 116.94 | 0.32 | 新进 | | 较上个报告期退出前十大股东有 | | | | | 胡志平 | 799.03 | 2.19 | 退出 | | 余林建 | 511.81 | 1.40 | 退出 | ...

Financial Performance - The company reported a basic earnings per share of -0.0092 yuan for Q1 2025, a decrease of 441.18% compared to -0.0017 yuan in Q1 2024 [1] - The net profit for Q1 2025 was -0.09 billion yuan, a significant decline of 350% from -0.02 billion yuan in Q1 2024 [1] - The operating revenue decreased by 21.21% to 2.86 billion yuan in Q1 2025 from 3.63 billion yuan in Q1 2024 [1] - The return on equity was -6.24% in Q1 2025, a drastic drop of 906.45% compared to -0.62% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 28,774.11 million shares, accounting for 30.44% of the circulating shares, with a decrease of 299.85 million shares from the previous period [1] - Notable shareholders include Hangzhou Fushi Asset Management Co., Ltd. with 7,572.51 million shares (8.01%) and Liu Wei with 6,683.27 million shares (7.07%), both remaining unchanged [2] - Song Chun Jing decreased holdings by 1,336.10 million shares, now holding 5,755.43 million shares (6.09%) [2] Dividend Policy - The company has announced that there will be no distribution or transfer of dividends this time [3]

前十大流通股东累计持有： 9060.27万股，累计占流通股比： 44.7%，较上期变化：0.00 。 | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | --- | | 北京哲厚新能源科技开发有限公司 | 2720.26 | 13.42 | 不变 | | 青岛中石大控股有限公司 | 1685.11 | 8.31 | 不变 | | 青岛军民融合发展集团有限公司 | 1520.10 | 7.50 | 不变 | | 青岛开发区投资建设集团有限公司 | 1520.10 | 7.50 | 不变 | | 东营齐源石油化工有限公司 | 410.81 | 2.03 | 不变 | | 北京托普瑞思能源贸易有限公司 | 326.14 | 1.61 | 不变 | | 北京昕惟商贸有限公司 | 268.06 | 1.32 | 不变 | | 北京铭哲恒达科技有限公司 | 263.49 | 1.30 | 不变 | | 山东惟普新材科技有限公司 | 199.99 | 0.99 | 不变 | | 东营市垦利区兴瑞通投资有限公司 | 146.21 | 0.72 | 不变 | ...